glp-1 lawsuit in kentucky gastrointestinal obstruction Gastrointestinal effects of GLP-1 receptor agonists: mechanisms, management GLP-1 Lawsuit Attorneys | Ashenden

Why pills matter: Easier to manufacture and distribute than cold-chain injectables, expanding global access and potentially lowering COGS

The evidence regarding those populations is the focus of this paper

Hydration Levels: GLP-1 medications can increase the risk of dehydration

This story originally appeared in the May 4, 2026 issue of Woman's World

Survey content The survey consisted of twelve items regarding years of practice, experience with GLP-1 RAs, knowledge of the ASAs 2023 guidance, degree of agreement with the ASAs 2023 guidance, barriers to guideline adherence, symptomatology that would lead to case cancellation, and the utility of gastric point-of-care ultrasound (POCUS)

One More Fly in the Ointment One year after withdrawal of once-weekly subcutaneous semaglutide 2.4 mg and lifestyle intervention, participants regained two-thirds of their prior weight loss, with similar changes in cardiometabolic variables